These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 33318300)
1. Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma. Fan T; Zhu M; Wang L; Liu Y; Tian H; Zheng Y; Tan F; Sun N; Li C; He J Aging (Albany NY); 2020 Dec; 13(2):2397-2417. PubMed ID: 33318300 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis. Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
4. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484 [TBL] [Abstract][Full Text] [Related]
5. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study. Chen G; Dong Z; Wu D; Chen Y J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059 [TBL] [Abstract][Full Text] [Related]
6. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465 [TBL] [Abstract][Full Text] [Related]
7. Establishment and Evaluation of a 6-Gene Survival Risk Assessment Model Related to Lung Adenocarcinoma Microenvironment. Wang Z; Xu H; Zhu L; He T; Lv W; Wu Z Biomed Res Int; 2020; 2020():6472153. PubMed ID: 32337264 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Wang J; Shi W; Miao Y; Gan J; Guan Q; Ran J Bioengineered; 2021 Dec; 12(1):6286-6304. PubMed ID: 34494914 [TBL] [Abstract][Full Text] [Related]
9. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Wu J; Li L; Zhang H; Zhao Y; Zhang H; Wu S; Xu B Oncogene; 2021 Jul; 40(26):4413-4424. PubMed ID: 34108619 [TBL] [Abstract][Full Text] [Related]
10. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861 [TBL] [Abstract][Full Text] [Related]
11. Identification of key genes in the tumor microenvironment of lung adenocarcinoma. Long W; Li Q; Zhang J; Xie H Med Oncol; 2021 Jun; 38(7):83. PubMed ID: 34117948 [TBL] [Abstract][Full Text] [Related]
12. Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma. Wu D; Liu Y; Liu J; Ma L; Tong X Sci Rep; 2024 Jul; 14(1):17460. PubMed ID: 39075165 [TBL] [Abstract][Full Text] [Related]
13. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma. Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q Front Immunol; 2021; 12():693062. PubMed ID: 34497605 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences. Fan T; Li C; He J Biol Sex Differ; 2021 Dec; 12(1):64. PubMed ID: 34863300 [TBL] [Abstract][Full Text] [Related]
15. Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment. Tan Q; Huang Y; Deng K; Lu M; Wang L; Rong Z; Zhao W; Li S; Xu Z; Fan L; Li K; Li Z J Cell Biochem; 2020 Nov; 121(11):4569-4579. PubMed ID: 32030808 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis. Bi G; Chen Z; Yang X; Liang J; Hu Z; Bian Y; Sui Q; Li R; Zhan C; Fan H Cancer Immunol Immunother; 2020 Jul; 69(7):1293-1305. PubMed ID: 32189030 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes. Chen F; Ma J; Hu S; Wu C; Chen S; Lin J Front Biosci (Landmark Ed); 2024 Apr; 29(4):135. PubMed ID: 38682187 [TBL] [Abstract][Full Text] [Related]
19. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li J; Xiao Y Biomed Res Int; 2020; 2020():8896511. PubMed ID: 33195699 [TBL] [Abstract][Full Text] [Related]